Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brecanavir is a tyrosyl-based arylsulfonamide, high affinity, protease inhibitor (PI) for the treatment of human immunodeficiency virus type 1.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | Brecanavir is a tyrosyl-based arylsulfonamide, high affinity, protease inhibitor (PI) for the treatment of human immunodeficiency virus type 1. |
Synonyms | GW-640385, GW-640385X, UNII-E367I8C7FI, CHEMBL206031, GW-0385 |
Molecular Weight | 703.82 |
Formula | C33H41N3O10S2 |
CAS No. | 313682-08-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Brecanavir 313682-08-5 GW-640385 CHEMBL-206031 CHEMBL 206031 GW-640385X UNII-E367I8C7FI GW 640385 GW 0385 GW0385 CHEMBL206031 GW-0385 GW640385 inhibitor inhibit